Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
Xiaomi Shares Jump on Europe EV Expansion Plan 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
France Targets Shein, Temu With Fast-Fashion Fees 
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
Anthropic Nears $15 Billion Credit Deal Ahead of IPO 
Milei Threatens Falkland Oil Firms With Sanctions 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
OpenAI Rejects Apple Trade Secret Theft Claims 
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Add as a preferred source on Google
RALEIGH, N.C., March 06, 2018 -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the Barclays Global Healthcare Conference in Miami. Mr. Macdonald’s presentation is scheduled for Tuesday, March 13, 2018, at 8:00 a.m. EDT.
Links to Syneos Health’s live presentation and archived audio replay, as well as the presentation materials, will be available via the Company’s Investor Relations website at investor.syneoshealth.com.
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit syneoshealth.com.
Contacts
Investor Relations:
Ronnie Speight
Vice President, Investor Relations
+1 919 745 2745
[email protected]
Press/Media:
Danielle DeForge
Senior Director, External Communications
+1 202 210 5992
[email protected]
